The team
April 7, 2021

Wound & tissue expert, Prof Ardeshir Bayat joins NuroKor Board as Chief Clinical & Scientific Advisor, Investor

Rick Rowan
Published on: 
April 7, 2021
NuroKor Team
Published on: 
December 21, 2022

Wound & tissue expert, Prof Ardeshir Bayat joins NuroKor Board as Chief Clinical & Scientific Advisor, Investor

NuroKor is delighted to welcome clinician scientist and world-renowned expert in wound healing, skin scarring and tissue repair, Professor Ardeshir Bayat - BSc (Hons) MB BS PhD, who joins the team as Chief Clinical & Scientific Advisor.


Ardeshir Bayat is a Medical Research Council funded Professor at the University of Cape Town in South Africa and Reader at the University of Manchester, UK and currently runs active translational research programmes in the UK and South Africa. One of his main areas of interest is on the use of bioelectronics in tissue healing and has spent many years gaining a deeper insight into the molecular science behind tissue healing and scar formation. In addition, he continues to explore the role of energy-based devices in enhancement of cutaneous wound healing and prevention of dermal fibrosis.


From physician to scientist, it was at the beginning of his clinical career that Ardeshir realised he had a niche focus and drive in translational research; “I have always been interested in how things work in the body, however, from very early on, the mechanism of tissue repair particularly caught my attention,” recalls Ardeshir. “Even in my training days as a junior trainee surgeon, I would question the impact of placing a suture and the trauma a foreign object like this could cause to the body’s recovery. Particularly when it wasn’t fully understood how the skin heals after suturing a patient.It was clear to me that in this time we were still quite limited in our understanding and practice of patient management in tissue repair. “


After completing his PhD in the molecular genetics of tissue repair, Ardeshir established a research lab to elucidate the mechanisms of tissue repair and possible treatment modalities that could translate from laboratory bench to patient bedside. Ardeshir explains, “I investigated a range of energy-based treatment modalities from light to ultrasound and one that really caught my eye was the role of electrical stimulation.”


Ardeshir has been involved in translational research for nearly twenty years and in particular bioelectronics research for more than a decade. He speaks extensively at conferences around the world on the topic,having given an impressive 560+ presentations as well as publishing over 480 articles in peer-reviewed journals.


As testament to his confidence in the company, our values and the potential for the technology, Ardeshir has also become one of Nurokor’s growing investor cohort. Rick Rowan, NuroKor CEO says, “We are incredibly proud to be working alongside a burgeoning team of clinical experts that have chosen to invest in NuroKor and truly believe in the power of bioelectronics to support better care, health and quality of life for people worldwide.”


In his role as Chief Clinical & Scientific Advisor, Ardeshir will be working with our scientific and medical teams to provide guidance, counsel and contributions to the scientific development and evidence of NuroKor’s products,across both pain management and wound care.


Sharing his enthusiasm for this new role, Ardeshir said:


“NuroKor is progressive and disruptive in equal measure, and I’m excited to have found a company that aligns so closely with my work, research and values. From my academic and clinical work, the real world evidence is undeniable and I really see enormous potential for bioelectronics in tissue repair. I am incredibly excited to be a part of a great team that is making a huge difference for people living with pain and injury, reducing the potential side effects of some medicines and reducing the need for invasive interventions.”

Dr Bayat is also a member of the GeneralMedical Council, Wound Healing Society, Wound Healing Foundation (Board ofDirectors) and the European Tissue Repair Society.

About NuroKor:

Founded in 2018, NuroKor is a company committed to the development of bioelectronic technologies. NuroKor develops and formulates programmable bioelectronic software for clinical and therapeutic applications, in a range of easy to use, wearable devices. It provides the highest-quality products, delivering personalised pain relief and recovery support and rehabilitation to patients.